Prevalence of Obstructive Sleep Apnea (OSA) after treatment for advance stage head and neck cancer

Prevalence of Obstructive Sleep Apnea (OSA) after treatment for advance stage head and neck cancer - Prevalence of sleepapnea after treatment for head and neck cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48756

Enrollment

196

Registered

2018-07-26

Start date

2019-09-12

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea sleep apnea

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: More than one year after treatment for T3-4 oral cavity, oropharynx, hypopharynx or larynx cancer.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
Prevalence of obstructive sleep apnea	—

Secondary

Measure	Time frame
Subgroups with a higher risk on obstructive sleep apnea and the difference in quality of life between patients with and without obstructive sleep apnea	—

Countries

Netherlands

Outcome results